Unknown PHASE1 INTERVENTIONAL 1-arm NCT01937416

Autologous Bone Marrow Mononuclear Cells Therapy in Diabetic Lower Limb Ischemia

Safety and Efficacy Investigation of Patients With Diabetic Lower Limb Ischemia by Transplantation of Autologous Bone Marrow Mononuclear Cells

Sponsor: Hebei Medical University

Conditions Diabetes Lower Limb Ischemia

Interventions autologous bone marrow mononuclear cells

Updated 6 times since 2017 Last updated: Dec 3, 2013 Started: Jan 31, 2012 Primary completion: Sep 30, 2013 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Diabetes and Lower Limb Ischemia, this trial is ongoing. The trial is conducted by Hebei Medical University and has accumulated 6 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE1

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hebei Medical University

Data source: Hebei Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shijiazhuang, China